Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 15 2021

Celiac Disease

  • Snapshot
    • A 43-year-old man from Ireland presents to the clinic with complaints of diarrhea. He reports she has been having 3-5 nonbloody, loose stools per day for the last 6 months and improves when he fasts. He denies hematochezia, melena, weight loss, or family history of colon cancer. A physical examination demonstrates blistering skin lesions at the extensor surfaces of the elbow bilaterally.
  • Introduction
    • Clinical definition
      • chronic autoimmune disorder triggered by an environmental agent (gliadin component of gluten) in genetically predisposed individuals
        • often found in wheat and other grains such as barley and rye
      • often develops in childhood but may develop at any age
    • Genetics
      • no single genetic marker exists
      • majority of patients have the variant HLA-DQ2 or HLA-DQ8 allele
        • these predisposing HLA risk alleles are necessary but not sufficient to develop celiac disease
    • Associated conditions
      • other autoimmune diseases (e.g., diabetes mellitus type 1)
  • Epidemiology
    • Demographics
      • occurs primarily in whites of northern European ancestry
      • > 1:5000 in North America
    • Pathogenesis
      • upon exposure to gluten, an abnormal immune response leads to the production of several different autoantibodies that affects different organs
        • leads to the formation of an immune complex in the intestinal mucosa (primarily at the small intestine)
      • presence of the immune complex promotes the aggregation of killer lymphocytes, which cause mucosal damage
        • leads to the loss of villi lining (villous atrophy) and proliferation of crypt cells
      • damage of the villi lining leads to dysfunction in nutrient absorption, leading to malabsorption and anemia
  • Presentation
    • Symptoms
      • steatorrhea
        • can lead to fat soluble vitamin deficiencies
      • abdominal pain
      • bloating
      • flatulence
      • weight loss/failure to gain weight
      • fatigue
      • some patients are asymptomatic
      • repeated infections (if IgA deficient, common in celiac patients)
        • anaphylaxis if transfused by IgA containing blood products
    • Physical exam
      • abdominal distension
      • pallor
      • mouth ulcers
      • short stature
      • dermatitis herpetiformis
        • pruritic, red, papulo-vesicular lesion commonly on shoulders, elbows, and knees
        • due to IgA deposits (anti-epidermal transglutaminase) in the upper dermis
  • Studies
    • Diagnostic testing
      • diagnostic approach
        • diagnosis is based on clinical symptoms and confirmed with small bowel biopsy
      • studies
        • serological blood tests
          • best initial test
            • anti-tissue transglutaminase (tTg)-IgA antibody
          • anti-endomysial-IgA antibody
            • tests for IgA antibodies, will be negative in those with IgA deficiency
              • for patients with IgA deficiency, deamidated gliadin peptide (DGP) IgG testing is available
          • positive serology requires small bowel biopsy for confirmation of diagnosis
        • upper endoscopy with small bowel biopsy
          • best confirmatory test
          • at least 4 duodenal biopsies are recommended
          • endoscopic features including loss of folds, visible fissures, nodularity, scalloping, and prominent submucosal vascularity
          • histologic features include
            • increased intraepithelial lymphocytes and plasma cells
            • atrophic mucosa with loss of villi
            • enhanced epithelial apoptosis
            • crypt hyperplasia
        • HLA testing
          • only useful in ruling out celiac disease
        • laboratory studies
          • CBC, iron studies, folic acid, vitamin B12 to evaluate level of malnutrition/malabsorption
        • dual energy X-ray absorptiometry (DEXA)
          • to identify risk of fracture and need for bone protection medication
  • Differential
    • Inflammatory bowel disease
      • distinguishing factors
        • different histological appearance on biopsy
    • Irritable bowel syndrome
      • distinguishing factors
        • will have negative biopsy results
  • Treatment
    • First-line
      • gluten-free diet
        • allows healing of the intestinal mucosa and resolution of all symptoms
        • eliminates the heighted risk of osteoporosis and intestinal cancer
      • dietary supplements
    • Second-line
      • steroids or immunosuppressant (e.g., azathioprine)
        • consider in patients with refractory disease
  • Complications
    • Iron deficiency anemia
    • Osteoporosis
    • Infertility
    • Neurological problems (secondary to malabsorption)
    • Intestinal lymphoma
      • develops in 10-15% of patients
1 of 0
1 of 10
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options